Details

Last Funding Type

Series D

Last Funding Money Raised

¥543M

Industries

Biotechnology,Health Care,Medical Device,Therapeutics

Founded date

Nov 1, 2008

Number Of Employee

1001 - 5000

Operating Status

Active

Biocytogen is a biopharmaceutical company that provides biomedical communities with integrated solutions for antibody drug development. Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including animal model generation, therapeutic antibody discovery (via RenMabTM Mouse), and in vivo/in vitro preclinical validation studies, using gene editing technologies and a state-of-the-art animal facility. Biocytogen works with the world's leading pharmaceutical and biotechnology companies.